Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
81,903,507
-
Shares change
-
+221,030
-
Total reported value, excl. options
-
$54,055,554
-
Value change
-
+$144,724
-
Number of buys
-
9
-
Number of sells
-
-2
-
Price
-
$0.6600
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q4 2022
20 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q4 2022.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81,903,507 shares
of 139,295,316 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (73,114,592 shares), Altium Capital Management LP (6,246,291 shares), VANGUARD GROUP INC (1,278,952 shares), RENAISSANCE TECHNOLOGIES LLC (606,310 shares), Crescent Grove Advisors, LLC (262,024 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (114,500 shares), CWM, LLC (100,000 shares), CITADEL ADVISORS LLC (43,658 shares), Midwest Professional Planners, LTD. (40,744 shares), and MILLENNIUM MANAGEMENT LLC (25,795 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.